CPLD 2014 FFBad vs Respondent M18

Facts
The French Badminton Federation (Fédération Française de Badminton, FFBad) charges respondent M18 for a violation of the Anti-Doping Rules. During a match on April 30, 2005, a sample was taken for doping test purposes. The analysis of the sample showed the presence of salbutamol which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent used medication containing the prohibited substance to treat asthma and respiratory problems. This was mentioned on the doping control form. He needs the medication to treat an immediate asthma attack, and has pulmonary function tests reports to prove his medical state.

Decision
1. The respondent is acquitted.
2. The decision will be not be published, it will be sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
2 March 2006
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Badminton (BWF) - Badminton World Federation
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Badminton (FFBad) - The French Badminton Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Asthma
Legitimate Medical Treatment
Respiratory disease
Document type
Pdf file
Date generated
25 September 2014
Date of last modification
1 October 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin